Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…
VERTEX PHARMACEUTICALS INC / MA
Last earnings +1.4% on 2026-05-04
Revenue grew 8.9% YoY.
Rules-based read computed from SEC figures — no Anthropic key set. Add ANTHROPIC_API_KEY to .env.local for a full Claude analysis.
VERTEX PHARMACEUTICALS INC / MA shows $12.0B in FY2025 revenue (+8.9% YoY), a 32.9% net margin, and 21.2% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro$19/mo · cancel anytime
Sources: SEC EDGAR (CIK 0000875320, latest 10-Q filed 2026-05-05) · EODHD · rules-based read · as of 6/17/2026, 6:06:13 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $7.57B | $8.93B | $9.87B | $11.0B | $12.0B |
| Gross profit | — | — | — | — | — |
| Operating income | $2.78B | $4.31B | $3.83B | -$233M | $4.17B |
| Net income | $2.34B | $3.32B | $3.62B | -$536M | $3.95B |
| Diluted EPS | $9.01 | $12.82 | $13.89 | -$2.08 | $15.32 |
| Net margin | 30.9% | 37.2% | 36.7% | -4.9% | 32.9% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
58 tracked peers · median
Last 90 days: 0 open-market buys · 6 sales
| 2026-06-05 | Bozic Carmen EVP and CMO | Sell | 1.75K @ $450.00 | $785K |
| 2026-06-01 | Liu Joy EVP and Chief Legal Officer | Sell | 828.00 @ $439.91 | $364K |
| 2026-05-29 | Bozic Carmen EVP and CMO | Sell | 1.97K @ $450.00 | $888K |
| 2026-05-15 | Bunnage Mark E. EVP, Chief Scientific Officer | Sell | 33.00 @ $453.45 | $15.0K |
| 2026-05-15 | Bozic Carmen EVP and CMO | Sell | 1.35K @ $453.45 | $614K |
| 2026-05-12 | Bozic Carmen EVP and CMO | Sell | 6.99K @ $450.00 | $3.14M |
| 2026-05-01 | Upadhyay Suketu Director | Disposed (D) | 796.00 | |
| 2026-05-01 | Thornberry Nancy Director | Award | 472.00 | |
| 2026-05-01 | Thornberry Nancy Director | Disposed (D) | 398.00 |